Literature DB >> 29345706

Tuning the nucleophilicity of electron-rich diborane(4) compounds with bridging guanidinate substituents by substitution.

Julian Horn1, Anna Widera, Sebastian Litters, Elisabeth Kaifer, Hans-Jörg Himmel.   

Abstract

Diborane(4) compounds are versatile reagents in synthetic chemistry. Generally, diboranes(4) with sp2-hybridized boron atoms react as electrophiles. By contrast, the chemistry of nucleophilic diborane(4) compounds with two sp3-hybridized boron atoms is very much underdeveloped. In this work, we systematically vary the substituents of electron-rich diborane(4) compounds with bridging guanidinate substituents. In this way, five new diboranes are synthesized and fully characterized. Using quantum chemical computations, we show that the electronic properties and reactivity of these compounds can be rationally varied by the choice of substituents. The HOMO energies, adiabatic ionization energies and proton affinities are considered as parameters to compare the chemical properties of these unusual compounds.

Entities:  

Year:  2018        PMID: 29345706     DOI: 10.1039/c7dt04433j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

1.  Polycationic Redox-Active Cyclophanes with Integrated Electron-Rich Diboron Units.

Authors:  Erik Filbeck; Anna Widera; Elisabeth Kaifer; Hans-Jörg Himmel
Journal:  Chemistry       Date:  2021-10-08       Impact factor: 5.020

2.  Bistriazoles Connected Through a B-B Bridge, Synthesized by Highly Selective Dipolar Cycloaddition Reactions of a Diazido-diborane(4).

Authors:  Daniel Vogler; Maximilian Schöner; Elisabeth Kaifer; Hans-Jörg Himmel
Journal:  Chemistry       Date:  2022-07-13       Impact factor: 5.020

3.  Directed Synthesis and Chemistry of Unsymmetric Dicationic Diboranes and Their Use in Frustrated Lewis Pair-like Chemistry.

Authors:  Lucas Kistner; Dario Kowatsch; Andreas Marz; Elisabeth Kaifer; Hans-Jörg Himmel
Journal:  Chemistry       Date:  2022-02-10       Impact factor: 5.020

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.